Minimal Residual Disease in Breast Cancer (original) (raw)
References
Henderson IC, Canellos GP: Cancer of the breast. N Engl J Med 302: 17–30, 1980 Google Scholar
Early Breast Cancer Trialists Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immunotherapy. Lancet 339: 1–15, 1992 Google Scholar
McGuire WL, Tandon AK, Allred DC, Chamness GC, Clark GM: How to use prognostic factors in axillary node-negative breast cancer patients. J Natl Cancer Inst 82: 1006–1115, 1990 Google Scholar
Mansi JL, Easton D, Berger U, Gazet J-C, Ford HT, Dearnaley et al.: Bone marrow micrometastases in primary breast cancer: prognostic significance after 6 years follow-up. Eur J Cancer 27: 1552–1555, 1991 Google Scholar
Diel IJ, Kaufmann M, Costa SD, Holle R, Minckwitz GV Solomayer EF, Kaul S, Bastert G: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. JNCO 88: 1652–1658, 1997 Google Scholar
Pantel K, Felber E, Schlimok G: Detection and characterization of residual disease in breast cancer. J Hematother 3: 315–322, 1994 Google Scholar
Cote RJ, Rosen PP, Lesser ML, Old LJ, Osborne MP: Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases. J Clin Oncol 9: 1749–1756, 1991 Google Scholar
Harbeck N, Untech M, Pache L, Eiermann W: Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up. Br J Cancer 69: 566–571, 1994 Google Scholar
Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, et al.: Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341: 85–86, 1993 Google Scholar
Moss TJ, Ross AA: The risk of tumor cell contamination in peripheral blood stem cell collections. J. Hematotherapy 1: 225–232, 1992 Google Scholar
Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TJ, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winther C, Akard L, Jansen J, Copelan E, Meagher R, Herzig RH, Klumpp TR, Kahn DG, Warner NE: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 82: 2605–2610, 1993 Google Scholar
Sharp JG, Mann SL, Murphy B, Weekes C: Culture methods for the detection of minimal tumor contamination of hematopoietic harvests: a review. J Hematother 4: 141–148, 1994 Google Scholar
Funke I, Schraut W: Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remain to be substantiated. JCO 16: 557–566, 1998 Google Scholar
Zippelius A, Kufer Å, Honold G, Kollermann MW, Oberneder R, Schlimok G, Rietmuller G, Pantel K: Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. JCO 15: 2701–2708, 1998 Google Scholar
Pantel K, Schlimok G, Angstwurm M, Weckermann D, Schmaus W, Gath H, Passlick B, Riethmuller G: Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow. J Hematother 3: 165–173, 1994 Google Scholar
Naume B, Borgen E, Beiske K, Herstad T-K, Ravnås G, Renolen A, Thrane-Steen K, Trachsel S, Funderud S, Kvalheim G: Detection of isolated breast cancer cells in peripheral blood or bone marrow by immunomagnetic techniques. J Hematother 6: 103–114, 1997 Google Scholar
Borgen E, Beiske K, Trachsel S, Nesland J, Kvalheim G, Herstad T, Schlichting E, Qvist H, Naume B: Immunocytochemical detection of isolated epithelial cells in bone marrow. Unspecific staining and contribution by plasma cells directly reactive to alkaline phosphatase. J Pathol 185: 427–434, 1998 Google Scholar
Gribben JG, Neuberg D, Freedman AS, Gimmi CD, Pesek KW, Barber M, Saporito L, Woo SD, Coral F, Spector N, Rabinowe SN, Grossbard ML, Ritz J, Nadler LM: Detection by polymerase chain reaction of residual cells with the bcl-2 translocation is associated with increased risk of relapse after autologous bone marrow transplantation for B-cell lymphoma. Blood 12: 3449–3457, 1993 Google Scholar
Lin F, Van Rhee F, Goldman JM, Cross NCP: Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 87: 4473–4478, 1996 Google Scholar
Datta YH, Adams PT, Drobyski WR, Ethier SP, Terry VH, Roth MS: Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Onc 12: 475–482, 1994 Google Scholar
Fields KK, Elfenbein GJ, Trudeau WL, Perkins JB, Janssen WE, Moscinski LC: Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high-dose chemotherapy and autologous bone marrow transplantation. J Clin Onc 14: 1868–1876, 1996 Google Scholar
Braun S, Muller M, Hepp F, Schlimok G, Riethmuller G, Pantel K: Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status. JNCI 14: 1099–1100, 1998 Google Scholar
Naume B, Borgen E, Kvalheim G, Giercksky KE, Ovist H, Schlichting E, Kåresen R, Nesland JM: Detection of isolated tumor cells in bone marrow in localised breast cancer. Abstract. 2nd International symposium on minimal residual cancer, 1998
Kvalheim G, Erikstein B, Hervik I, Pharo A, Sommer H, Anker G, Telhaug R, Kolstad A, Nesland JM: Micrometastases in marrow and blood in high-risk stage II breast cancers before/after high-dose therapy. Blood 90;Suppl 1: 443a, 1998 Google Scholar
Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L: Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83: 636–640, 1994 Google Scholar
Schlimok K, Pantel K, Loibner H, Fackler-Schwalbe I, Riethmuller G: Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours. Eur J Cancer 11: 1799–1803, 1995 Google Scholar
Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnås G, Qvist H, Kåresen R, Kvalheim G: Increased sensitivity for detection of micrometastases in bone-marrow/ peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Int J Cancer 78: 556–560, 1998 Google Scholar
Pantel K, Felber E, Schlimok G: Detection and characterization of residual disease in breast cancer. J Hematother 3: 315–322, 1994 Google Scholar
Disis ML, Cheever MA, HER-2/neu protein: a target for antigen-specific immunotherapy of human cancer. Avd Cancer Res 71: 343–371, 1997 Google Scholar